These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2022925)

  • 1. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance.
    Neta R; Oppenheim JJ; Schreiber RD; Chizzonite R; Ledney GD; MacVittie TJ
    J Exp Med; 1991 May; 173(5):1177-82. PubMed ID: 2022925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice.
    Boelen A; Platvoet-ter Schiphorst MC; Wiersinga WM
    J Endocrinol; 1997 Apr; 153(1):115-22. PubMed ID: 9135576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
    Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-kit ligand/steel factor by antibodies reduces survival of lethally irradiated mice.
    Neta R; Williams D; Selzer F; Abrams J
    Blood; 1993 Jan; 81(2):324-7. PubMed ID: 7678509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo.
    Perlstein RS; Whitnall MH; Abrams JS; Mougey EH; Neta R
    Endocrinology; 1993 Mar; 132(3):946-52. PubMed ID: 8382602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.
    DeForge LE; Kenney JS; Jones ML; Warren JS; Remick DG
    J Immunol; 1992 Apr; 148(7):2133-41. PubMed ID: 1545121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor.
    Neta R; Perlstein R; Vogel SN; Ledney GD; Abrams J
    J Exp Med; 1992 Mar; 175(3):689-94. PubMed ID: 1311016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endogenous cytokines in endotoxin- and interleukin-1-induced pulmonary inflammatory response and oxygen tolerance.
    Tang G; White JE; Lumb PD; Lawrence DA; Tsan MF
    Am J Respir Cell Mol Biol; 1995 Mar; 12(3):339-44. PubMed ID: 7873200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats.
    Karkar AM; Koshino Y; Cashman SJ; Dash AC; Bonnefoy J; Meager A; Rees AJ
    Clin Exp Immunol; 1992 Nov; 90(2):312-8. PubMed ID: 1385027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
    Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6.
    Neta R; Vogel SN; Plocinski JM; Tare NS; Benjamin W; Chizzonite R; Pilcher M
    Blood; 1990 Jul; 76(1):57-62. PubMed ID: 2142008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.
    Johnson CS; Pourbohloul SC; Furmanski P
    Exp Hematol; 1991 Feb; 19(2):101-5. PubMed ID: 1991491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin.
    Kayama F; Yoshida T; Kodama Y; Matsui T; Matheson JM; Luster MI
    Cytokine; 1997 Sep; 9(9):688-95. PubMed ID: 9325018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.